Ginkgo Bioworks DNA Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Ginkgo Bioworks’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ginkgo Bioworks's operating lease liabilities (current)?
- Ginkgo Bioworks (DNA) reported operating lease liabilities (current) of $22.79M in Q4 2025.
- How has Ginkgo Bioworks's operating lease liabilities (current) changed year-over-year?
- Ginkgo Bioworks's operating lease liabilities (current) decreased by 20.4% year-over-year, from $28.63M to $22.79M.
- What is the long-term trend for Ginkgo Bioworks's operating lease liabilities (current)?
- Over 4 years (2021 to 2025), Ginkgo Bioworks's operating lease liabilities (current) has grown at a -39.2% compound annual growth rate (CAGR), from $166.7M to $22.79M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.